3KH-77240-32342
2 vaccinations
3 coded responses
20 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 921 / CA
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Registered in v-safe
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
-
2021-04-24
Dose 2 — Pfizer-BioNTech
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-30
-
2021-05-01
Survey response — day 7, dose 2MedDRA: Headache, Ocular discomfort — Feeling: Good · Fatigue or tirednessFree text: On April 24, i missed work due to severe headache, eye pressure, and feeling very beat. Never thought it may have been related to the vaccination.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-15
- 2021-05-24
- 2021-07-24
-
2021-10-23
Survey response — 6 months, dose 2MedDRA: Arthralgia, Injury, Ligament sprain, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Sprained knee and high degree of pain from the injury for several months. After seeing doctors and physical therapy, now doing better yet it made feelings of isolation to increase. Working from home since March 2020 has been hard and life changing. · Healthcare visit (other): Doctor's office visits.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-23
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-10-26
-
2022-04-24
Survey response — 12 months, dose 2MedDRA: Ageusia, Anosmia, Fatigue, Headache, Influenza virus test, Medical counselling, Mental impairment, Office visit, Pain, Pyrexia, SARS-CoV-2 test — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Fever, body aches and pain, terrible headache, clouded thinking, loss of taste and smell, very tired. · Healthcare visit (other): Doctor office visit and was tested for flu and covid. Followed by virtual appointment.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 8 — day 7, dose 2
Systemic reaction (other): On April 24, i missed work due to severe headache, eye pressure, and feeling very beat. Never thought it may have been related to the vaccination.
Release 10 — 6 months, dose 2
Symptoms: Sprained knee and high degree of pain from the injury for several months. After seeing doctors and physical therapy, now doing better yet it made feelings of isolation to increase. Working from home since March 2020 has been hard and life changing. cut off by CDC
Healthcare visit (other): Doctor's office visits.
Release 11 — 12 months, dose 2
Symptoms: Fever, body aches and pain, terrible headache, clouded thinking, loss of taste and smell, very tired.
Healthcare visit (other): Doctor office visit and was tested for flu and covid. Followed by virtual appointment.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Influenza virus test | · | · | ✓ |
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| HCVO | SARS-CoV-2 test | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injury | · | · | ✓ |
| SD | Ligament sprain | · | · | ✓ |
| SD | Mental impairment | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Ocular discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release